Kolexia
Miroir Jessica Oncologie radiothérapie
Miroir Jessica
Oncologie radiothérapie
Centre Jean-Perrin
Clermont-Ferrand, France
64 Activités
189 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Tumeurs de la tête et du cou Carcinome épidermoïde de la tête et du cou Métastase tumorale Métastase lymphatique Récidive tumorale locale Tumeurs du crâne Troubles de la déglutition

Collaborateurs

Voir plus
Lapeyre Michel
Lapeyre Michel
Centre Jean-Perrin, Clermont-Ferrand, France
Biau Julian
Biau Julian
Centre Jean-Perrin, Clermont-Ferrand, France
Saroul Nicolas
Saroul Nicolas
Hôpital Gabriel Montpied, Clermont-Ferrand, France
Pham Dang Nathalie
Pham Dang Nathalie
Hôpital Estaing, Clermont-Ferrand, France

Industries

Voir plus
Ipsen
1 collaboration(s)
Dernière en 2021
Bouchara-Recordati
1 collaboration(s)
Dernière en 2023
Astellas
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy.
Frontiers in oncology   31 octobre 2023
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
REACH: A Phase III Randomized Trial of Avelumab-cetuximab-Radiotherapy Versus Standards of Care in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Essai Clinique (Groupe d'Oncologie Radiothérapie Tête Et Cou)   19 juin 2023
STEP: Phase II Study to Assess Preoperative Hypofractionated Stereotactic Radiotherapy of Brain Metastases
Essai Clinique (Centre Jean-Perrin)   07 février 2023
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
European journal of cancer (Oxford, England : 1990)   09 janvier 2023
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology   28 octobre 2022
Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial: A Phase I/II Randomized Study to Determine the Maximum Tolerated Dose, Safety, Pharmacokinetics and Antitumor Activity of Debio 1143 Combined With Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Essai Clinique (Debiopharm)   22 juin 2022
ETOILE: Transnational Randomized Study Comparing Carbon Ions Therapy Versus Conventional Radiotherapy - Including Protontherapy - for the Treatment of Radioresistant Tumors
Essai Clinique (Hospices Civils de Lyon)   01 septembre 2021
LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary.
Cancers   17 mai 2021